Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × MK 2206 × Clear all

NCT01251861 2026-05-29

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

Phase 2 Active not recruiting

108 enrolled 16 charts

Prostatic Neoplasms